BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8340401)

  • 1. Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide.
    Holmes DF; Watson RB; Steinmann B; Kadler KE
    J Biol Chem; 1993 Jul; 268(21):15758-65. PubMed ID: 8340401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
    Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
    J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface located procollagen N-propeptides on dermatosparactic collagen fibrils are not cleaved by procollagen N-proteinase and do not inhibit binding of decorin to the fibril surface.
    Watson RB; Holmes DF; Graham HK; Nusgens BV; Kadler KE
    J Mol Biol; 1998 Apr; 278(1):195-204. PubMed ID: 9571043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
    Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
    J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
    Chiodo AA; Hockey A; Cole WG
    J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of collagen fibrils by enzymic cleavage of precursors of type I collagen in vitro.
    Miyahara M; Hayashi K; Berger J; Tanzawa K; Njieha FK; Trelstad RL; Prockop DJ
    J Biol Chem; 1984 Aug; 259(15):9891-8. PubMed ID: 6430905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology of sheet-like assemblies of pN-collagen, pC-collagen and procollagen studied by scanning transmission electron microscopy mass measurements.
    Holmes DF; Mould AP; Chapman JA
    J Mol Biol; 1991 Jul; 220(1):111-23. PubMed ID: 2067010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
    Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
    Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.
    Steinmann B; Tuderman L; Peltonen L; Martin GR; McKusick VA; Prockop DJ
    J Biol Chem; 1980 Sep; 255(18):8887-93. PubMed ID: 6773953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
    Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
    J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
    Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
    J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembly of collagen I from a proband homozygous for a mutation that substituted serine for glycine at position 661 in the alpha 2(I) chain. Possible relationship between the effects of mutations on critical concentration and the severity of the phenotype.
    Romanic AM; Spotila LD; Adachi E; Engel J; Hojima Y; Prockop DJ
    J Biol Chem; 1994 Apr; 269(15):11614-9. PubMed ID: 8157695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The arthrochalasia type of Ehlers-Danlos syndrome (EDS VIIA and VIIB): the diagnostic value of collagen fibril ultrastructure.
    Giunta C; Chambaz C; Pedemonte M; Scapolan S; Steinmann B
    Am J Med Genet A; 2008 May; 146A(10):1341-6. PubMed ID: 18409203
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.
    Hirose T; Takahashi N; Tangkawattana P; Minaguchi J; Mizumoto S; Yamada S; Miyake N; Hayashi S; Hatamochi A; Nakayama J; Yamaguchi T; Hashimoto A; Nomura Y; Takehana K; Kosho T; Watanabe T
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):623-631. PubMed ID: 30553867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphism in type I collagen fibrils produced by persistence of the procollagen N-propeptide.
    Hulmes DJ; Kadler KE; Mould AP; Hojima Y; Holmes DF; Cummings C; Chapman JA; Prockop DJ
    J Mol Biol; 1989 Nov; 210(2):337-45. PubMed ID: 2600969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII.
    Cole WG; Chan D; Chambers GW; Walker ID; Bateman JF
    J Biol Chem; 1986 Apr; 261(12):5496-503. PubMed ID: 3082886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis.
    Smith LT; Schwarze U; Goldstein J; Byers PH
    J Invest Dermatol; 1997 Mar; 108(3):241-7. PubMed ID: 9036918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, morphological, and biochemical phenotype of a new case of Ehlers-Danlos syndrome type VIIC.
    Fujimoto A; Wilcox WR; Cohn DH
    Am J Med Genet; 1997 Jan; 68(1):25-8. PubMed ID: 8986271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructure study of skin fibroblasts in patients with Ehlers-Danlos Syndrome (EDS): preliminary results.
    Celli M; Iacovino C; Febbo A; Lotti LV; Miraglia E; Celli L; Roberti V; Sernicola A; Zambrano A; Turchetti A; Vespa S; Giustini S
    Clin Ter; 2020; 171(5):e431-e436. PubMed ID: 32901788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.